Filter
394
Filtered Results: 394
Text search:
leishmaniosis
Featured
Recommendations
46
New Publications
87
Language
Document type
No document type
145
Studies & Reports
93
Guidelines
50
Strategic & Response Plan
25
Manuals
22
Resource Platforms
16
Videos
16
Fact sheets
11
Training Material
5
Infographics
5
Situation Updates
4
Dashboards/Maps
1
Online Courses
1
Countries / Regions
Global
54
Latin America and the Carribbean
19
Ethiopia
14
Paraguay
13
India
12
Colombia
11
Syria
11
Nepal
9
Kenya
8
Bangladesh
8
Africa
7
Middle East and North Africa
5
Western and Central Europe
5
Uganda
5
Sudan
5
Venezuela
4
Jordan
4
Brazil
4
Ghana
3
Nigeria
3
Congo, Democratic Republic of
3
Bolivia
3
Lebanon
3
Zambia
3
South Sudan
3
Iraq
3
Somalia
3
Turkey
2
Iran
2
Malawi
2
Saudi Arabia
2
South–East Asia Region
2
East and Southern Africa
2
Eastern Europe
2
Pakistan
2
North Macedonia
1
Sierra Leone
1
Togo
1
China
1
Rwanda
1
Cameroon
1
Albania
1
Afghanistan
1
Peru
1
Morocco
1
Qatar
1
Cambodia
1
Asia
1
Tanzania
1
Germany
1
North America
1
Tunisia
1
South Africa
1
Djibouti
1
Egypt
1
Yemen
1
Greece
1
Palestine
1
Georgia
1
Honduras
1
Angola
1
Chad
1
Libya
1
Indonesia
1
Liberia
1
Ecuador
1
Myanmar / Burma
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
119
Clinical Guidelines
56
Public Health
35
Key Resources
20
Pharmacy & Technologies
5
Capacity Building
4
Women & Child Health
4
Toolboxes
NTDs
156
Planetary Health
23
HIV
16
Conflict
12
Rapid Response
11
COVID-19
8
Global Health Education
8
Refugee
7
Caregiver
5
TB
4
NCDs
4
Pharmacy
3
Natural Hazards
2
Health Financing Toolbox
2
Zika
2
Mental Health
1
Disability
1
Cholera
1
Ebola & Marburg
1
Malaria
1
Polio
1
AMR
1
Website last accessed on 04.06.2023
Treatment options for Visceral Leishmaniasis in HIV-coinfected people include oral miltefosine; find additional information on diagnosis and ART treatment.
Visceral leishmaniasis, the most severe form of leishmaniasis also known as kala-azar, is a life-threatening disease caused by Leishmania parasites which are transmitted by female sandflies. Visceral leishmaniasis causes fever, weight loss, spleen and liver enlargement, and, if not treated, death. P...
Website last accessed on 04.06.2023
Youtube Video
During the Programme Managers’ Review Meeting of Central and East Africa and South-East Asia (online meeting, June 2022), experts proposed additional regional and national subtargets related to VL incidence, as defined below. These targets can be revisited as progress is reviewed and access to dia...
The Leishmaniasis East Africa Platform (LEAP) was established to support the generation of scientific evidence for the development and distribution of new treatments for leishmaniasis in Eastern Africa.
This report on global leishmaniasis surveillance follows those published in 2016–2023.2–6 Six indicators of leishmaniasis are publicly available from the Global Health Observatory (GHO).7 In addition to the GHO, country profiles with up to 30 indicators are published, with detailed data received...
Leishmaniasis is a parasitic disease caused by the Leishmania parasite. This parasite typically lives in infected sand flies. You can contract leishmaniasis from a bite of an infected sand fly.
The sand flies that carry the parasite typically reside in tropical and subtropical environments. Fatal...
Leishmaniasis is a vector-borne tropical/subtropical disease caused by an intracellular parasite transmitted to humans by sand fly bite. It is endemic in Asia, Africa, the Americas, and the Mediterranean region. Worldwide reports include 1.5–2 million new cases each year, more than 300 million at ...
Website last accessed on 04.06.2023
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from ...
Website last accessed on 22.05.2023
Leishmaniasis refers to a diverse group of diseases caused by single-celled parasites called Leishmania. About 12 million people are infected at any one time, causing up to 40,000 deaths annually.
The VALIDATE Network - Vaccine development for complex intra...
Rreport of a WHO Consultative Meeting Kolkata India 2012
Leishmaniasis is a parasitic disease that is found in parts of the tropics, subtropics, and southern Europe. Leishmaniasis is caused by infection with Leishmania parasites, which are spread by the bite of infected sand flies. There are several different forms of leishmaniasis in people. The most com...
Leishmaniasis is a climate-sensitive disease. Changes in temperature, rainfall, and humidity can have strong impacts on
the sandfly vector, altering their distribution and influencing their survival and population sizes. Increased temperatures shorten vector development time, reduce Leishmania para...
Leishmaniasis is a vector-borne disease with a broad global distribution and an increasing number of recorded cases worldwide. However, it is still one of the world's most neglected diseases. Over the last decades, the disease has been found to expand geographically with a global increase of cases o...
Video last accessed on 04.06.2023
Video Dailymotion
Website last accessed on 08.05.2023
Identificar las formas de transmisión de la leishmaniasis - Youtube Video
El manual tiene por objetivo ampliar los conocimientos sobre la enfermedad y aspira a ser una herramienta de trabajo para que el personal de salud y los equipos de gestión presten apoyo a los ministerios de salud en sus respectivos procesos de estructuración de los servicios de salud, así como en...
We reviewed the evidence on community-based interventions for the prevention and control of cutaneous leishmaniasis (CL). Community initiatives tailored towards awareness and mobilisation are regarded as a priority area in the Neglected Tropical Disease Roadmap 2021–2030 by the World Health Organi...
